quisqualic acid has been researched along with Nerve Degeneration in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lisý, V; Stastný, F | 1 |
| Bellucci, A; Casamenti, F; Giovannini, MG; Pepeu, G; Prosperi, C; Scali, C | 1 |
| Yezierski, RP; Yu, CG | 1 |
| Donaldson, PL; Duce, IR; Usherwood, PN | 1 |
| Bendahan, G; Bjelke, B; Boatell, ML; Fuxe, K; Mahy, N; Olson, L; Tinner, B | 1 |
| Monard, D; Nitsch, C; Scotti, AL | 1 |
| Cline, HT; Constantine-Paton, M; McDonald, JW | 1 |
| Duberley, RM; Ham, J; Rickards, CR; Scanlon, MF | 1 |
| Madsen, PW; Park, SH; Santana, M; Yezierski, RP | 1 |
| Jarrard, LE; Meldrum, BS | 1 |
| Olney, JW; Price, MT; Yamada, KA; Zorumski, CF | 1 |
| Power, AE; Ramirez, GA; Thal, LJ; Winkler, J | 1 |
| Brewer, KL; Casey, KL; Morrow, TJ; Paulson, PE; Yezierski, RP | 1 |
| Casamenti, F; Pepeu, G; Prosperi, C; Scali, C; Vannucchi, MG | 1 |
| Battaglia, G; Bruno, V; Ceña, V; Cespédes, VM; Copani, A; Flor, PJ; Galindo, MF; Gasparini, F; Kuhn, R; Nicoletti, F; Sánchez-Prieto, J | 1 |
| Olney, JW; Pathikonda, M; Snider, WD; Stewart, GR | 1 |
| Henderson, Z | 1 |
| Leander, JD; Ornstein, PL; Salhoff, CR; Schoepp, DD | 1 |
| Coyle, JT; Miyamoto, M | 1 |
| Bernardi, G; Calabresi, P; De Murtas, M; Mercuri, NB | 1 |
| Morgan, IG | 1 |
| Benavides, J; Carter, C; Fage, D; Scatton, B | 1 |
| Meldrum, B | 1 |
23 other study(ies) available for quisqualic acid and Nerve Degeneration
| Article | Year |
|---|---|
Nitric oxide synthase inhibition and glutamate binding in quinolinate-lesioned rat hippocampus.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Binding, Competitive; Cell Membrane; Excitatory Amino Acid Agonists; Glutamic Acid; Hippocampus; Kainic Acid; Male; Molsidomine; N-Methylaspartate; Nerve Degeneration; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Quinolinic Acid; Quisqualic Acid; Rats; Rats, Wistar; Tritium | 2002 |
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.
Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Cell Death; Choline O-Acetyltransferase; Cholinergic Fibers; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Encephalitis; Gliosis; Isoenzymes; Lactones; Male; Microglia; Mitogen-Activated Protein Kinases; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Quisqualic Acid; Rats; Rats, Wistar; Sulfones | 2003 |
Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury.
Topics: Animals; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Genes, Regulator; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nerve Degeneration; Pain; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Spinal Cord; Spinal Cord Injuries; Transcription Factors; Up-Regulation | 2005 |
Investigations into the mechanism of excitant amino acid cytotoxicity using a well-characterized glutamatergic system.
Topics: Animals; Aspartic Acid; Concanavalin A; Cysteine; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Grasshoppers; Kainic Acid; Nerve Degeneration; Neuromuscular Junction; Neurotransmitter Agents; Oxadiazoles; Quisqualic Acid; Receptors, Cell Surface; Receptors, Glutamate; Synaptic Transmission | 1983 |
Differential brain area vulnerability to long-term subcortical excitotoxic lesions.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Damage, Chronic; Calcium; Immunohistochemistry; Male; Nerve Degeneration; Neurotoxins; Prosencephalon; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Septal Nuclei | 1995 |
Re-expression of glia-derived nexin/protease nexin 1 depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra.
Topics: Amyloid beta-Protein Precursor; Animals; Carrier Proteins; Glial Fibrillary Acidic Protein; Ibotenic Acid; Immunohistochemistry; Male; N-Methylaspartate; Nerve Degeneration; Oxidopamine; Protease Nexins; Putamen; Quisqualic Acid; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Glutamate; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 1994 |
Glutamate receptor binding in juvenile and adult Rana pipiens CNS.
Topics: Afferent Pathways; Animals; Axons; Brain; Eye Enucleation; Horseradish Peroxidase; N-Methylaspartate; Nerve Degeneration; Quisqualic Acid; Rana pipiens; Receptors, Glutamate | 1994 |
Glutamate neurotoxicity: a role for non-N-methyl-D-aspartate receptors?
Topics: Animals; Brain; Cells, Cultured; Choline O-Acetyltransferase; Glutamates; Glutamic Acid; Kainic Acid; N-Methylaspartate; Nerve Degeneration; Quisqualic Acid; Rats; Receptors, N-Methyl-D-Aspartate; Somatostatin | 1993 |
Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat.
Topics: Animals; Behavior, Animal; Glial Fibrillary Acidic Protein; Grooming; Male; Microinjections; Nerve Degeneration; Neurons; Quisqualic Acid; Rats; Spinal Cord | 1993 |
Selective excitotoxic pathology in the rat hippocampus.
Topics: Animals; Brain; Brain Damage, Chronic; Cell Death; Hippocampus; Ibotenic Acid; Kainic Acid; Male; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Organ Specificity; Piperazines; Quisqualic Acid; Rats; Rats, Sprague-Dawley | 1993 |
A benzodiazepine recognition site associated with the non-NMDA glutamate receptor.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Binding Sites; Binding, Competitive; Cells, Cultured; Chick Embryo; Electric Conductivity; Excitatory Amino Acid Antagonists; Hippocampus; Kainic Acid; Nerve Degeneration; Neurons; Quisqualic Acid; Rats; Receptors, Glutamate; Retina | 1993 |
Short-term and complete reversal of NGF effects in rats with lesions of the nucleus basalis magnocellularis.
Topics: Animals; Biogenic Monoamines; Body Weight; Brain; Choline O-Acetyltransferase; Excitatory Amino Acid Agonists; Male; Nerve Degeneration; Nerve Growth Factors; Quisqualic Acid; Rats; Rats, Inbred F344; Substantia Innominata; Time Factors | 1998 |
Chronic, selective forebrain responses to excitotoxic dorsal horn injury.
Topics: Afferent Pathways; Animals; Cerebrovascular Circulation; Chronic Disease; Excitatory Amino Acid Agonists; Male; Nerve Degeneration; Neuronal Plasticity; Neurotoxins; Posterior Horn Cells; Prosencephalon; Quisqualic Acid; Rats; Rats, Long-Evans; Sensation Disorders; Somatosensory Cortex; Spinal Cord Injuries | 2000 |
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Choline O-Acetyltransferase; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Encephalitis; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Gliosis; Interleukin-1; Isoenzymes; Male; Microscopy, Electron; Nerve Degeneration; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Prostaglandin-Endoperoxide Synthases; Quisqualic Acid; Rats; Rats, Wistar; Sulfonamides | 2000 |
An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Enzyme Activation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Mice; N-Methylaspartate; Nerve Degeneration; Neural Inhibition; Neuroprotective Agents; Neurotoxins; Protein Kinase C; Quisqualic Acid; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Time Factors | 2001 |
Excitotoxicity in the embryonic chick spinal cord.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids, Diamino; Animals; beta-Alanine; Chick Embryo; Cyanobacteria Toxins; Dizocilpine Maleate; Glutamates; Glutamic Acid; Ibotenic Acid; Kainic Acid; Motor Neurons; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Quinoxalines; Quisqualic Acid; Spinal Cord | 1991 |
Sprouting of cholinergic axons does not occur in the cerebral cortex after nucleus basalis lesions.
Topics: Acetylcholinesterase; Animals; Axonal Transport; Axons; Cholinergic Fibers; Ferrets; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Quisqualic Acid; Rats; Receptors, Cell Surface; Receptors, Nerve Growth Factor; Visual Cortex | 1991 |
Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Female; Ibotenic Acid; Isoquinolines; Kainic Acid; Male; N-Methylaspartate; Nerve Degeneration; Quisqualic Acid; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins.
Topics: Animals; Apomorphine; Benzoquinones; Choline O-Acetyltransferase; Corpus Striatum; Glutamate Decarboxylase; Histocytochemistry; Kainic Acid; Kinetics; Male; Motor Activity; NADPH Dehydrogenase; Nerve Degeneration; Oxadiazoles; Pyridines; Quinolinic Acid; Quinolinic Acids; Quinones; Quisqualic Acid; Rats; Rats, Inbred Strains; Ubiquinone | 1990 |
Kainic acid on neostriatal neurons intracellularly recorded in vitro: electrophysiological evidence for differential neuronal sensitivity.
Topics: Action Potentials; Animals; Cell Membrane; Corpus Striatum; Dose-Response Relationship, Drug; In Vitro Techniques; Kainic Acid; Kynurenic Acid; Male; Membrane Potentials; N-Methylaspartate; Nerve Degeneration; Neural Conduction; Neurons; Quisqualic Acid; Rats; Rats, Inbred Strains | 1990 |
AMPA is a powerful neurotoxin in the chicken retina.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Chickens; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Ibotenic Acid; Injections; Kainic Acid; N-Methylaspartate; Nerve Degeneration; Oxadiazoles; Oxazoles; Quisqualic Acid; Retina; Retinal Ganglion Cells; Vitreous Body | 1987 |
Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Binding Sites; Choline O-Acetyltransferase; Corpus Striatum; Glutamate Decarboxylase; Ibotenic Acid; Kainic Acid; Male; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Oxadiazoles; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1987 |
Excitatory amino acid antagonists as novel anticonvulsants.
Topics: Amino Acids, Dicarboxylic; Animals; Anticonvulsants; Aspartic Acid; Epilepsy; Glutamates; Kainic Acid; N-Methylaspartate; Nerve Degeneration; Nervous System Diseases; Oxadiazoles; Quisqualic Acid; Receptors, Amino Acid; Receptors, Cell Surface; Structure-Activity Relationship | 1986 |